Aslani, Jack Perez .
HRN: 22-76-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
CEFTRIAXONE 1G (VIAL)
10/19/2025
10/26/2025
IV
1gm
Q24
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes